National Cancer Institute Will Stop Funding Nanotechnology Centers

The Centers of Cancer Nanotechnology Excellence were established in 2005 through several phases of funding, which are reported to end next year.

Written byChia-Yi Hou
| 1 min read
national cancer institute nci funding grants nanotechnology centers

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share

ABOVE: National Cancer Institute in Maryland
NATIONAL CANCER INSTITUTE

The US National Cancer Institute announced that next year it will stop funding the Centers of Cancer Nanotechnology Excellence, reports Science. The Centers encompasses several research groups at various institutions, including Caltech, the University of California, Los Angeles, Northwestern University, Cornell University, and others, according to its website.

The Centers of Cancer Nanotechnology Excellence (CCNEs) focus on developing nanotechnology for cancer treatment. The end to funding represents a “natural transition” from putting dedicated support into an emerging field to becoming a more mature research field that fits in with other cancer fields, says Piotr Grodzinski of the National Cancer Institute’s (NCI) Nanodelivery Systems and Devices Branch, which oversees the CCNEs, to Science.

The CCNEs started in 2005 as eight research groups in the first phase, nine getting funding in 2010 in the second phase, and six funded in 2015 for the third ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here
Image of small blue creatures called Nergals. Some have hearts above their heads, which signify friendship. There is one Nergal who is sneezing and losing health, which is denoted by minus one signs floating around it.
June 2025, Issue 1

Nergal Networks: Where Friendship Meets Infection

A citizen science game explores how social choices and networks can influence how an illness moves through a population.

View this Issue
Illustrated plasmids in bright fluorescent colors

Enhancing Elution of Plasmid DNA

cytiva logo
An illustration of green lentiviral particles.

Maximizing Lentivirus Recovery

cytiva logo
Explore new strategies for improving plasmid DNA manufacturing workflows.

Overcoming Obstacles in Plasmid DNA Manufacturing

cytiva logo
Unraveling Complex Biology with Advanced Multiomics Technology

Unraveling Complex Biology with Five-Dimensional Multiomics

Element Bioscience Logo

Products

The Scientist Placeholder Image

Waters Enhances Alliance iS HPLC System Software, Setting a New Standard for End-to-End Traceability and Data Integrity 

The Scientist Placeholder Image

Agilent Unveils the Next Generation in LC-Mass Detection: The InfinityLab Pro iQ Series

agilent-logo

Agilent Announces the Enhanced 8850 Gas Chromatograph

parse-biosciences-logo

Pioneering Cancer Plasticity Atlas will help Predict Response to Cancer Therapies